Ion channel targets
Print ISSN 1933-6950; Online ISSN 1933-6969

Important News: Channels has been accepted for indexing at PubMed.

Recommend Channels to your librarian for 2008. Download form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Addenda

Block of Nav1.8 by Small Molecules

Douglas S. Krafte, Mark Chapman, Brian Marron, Robert Atkinson, Yi Liu, Fei Yu, Michael Kort and Michael F. Jarvis

volume 1 | issue 3

May/June 2007
Pages: 152 - 153

We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.

Sodium channels are key proteins in regulating neuronal excitability and accumulating data suggest that specific subtypes of voltage-dependent sodium channels are important in signaling various types of pain. Consistent with this theme, Jarvis et al (2007) recently reported the identification of a subtype-selective Nav1.8 blocker that was active in several pre-clinical models of pain. During the course of these studies compounds were also identified that showed large differences in potency when tested on Nav1.8 channels from different species. This Addendum illustrates one of these compounds along with the potency correlation between recombinant and native tetrodotoxin-resistant sodium channels for additional examples. These data show that significant differences can be observed for sodium channel blockers across species and highlight the importance of considering this possibility when searching for new compounds and research tools to probe sodium channel function.

Authors

Douglas S. Krafte

Icagen, Inc.; Durham, North Carolina USA

Mark Chapman

Icagen, Inc.; Durham, North Carolina USA

Brian Marron

Icagen, Inc.; Durham, North Carolina USA

Robert Atkinson

Icagen, Inc.; Durham, North Carolina USA

Yi Liu

Icagen, Inc.; Durham, North Carolina USA

Fei Yu

Icagen, Inc.; Durham, North Carolina USA

Michael Kort

Abbott Laboratories

Michael F. Jarvis

Abbott Laboratories



We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.